Duration of adjuvant chemotherapy; Anthracyclines, taxanes and novel agents - More or less

被引：5

作者：

Barrett-Lee, P ^{[1
]}

Ellis, P

Bliss, J

机构：

[1] Velindre NHS Trust, Cardiff, S Glam, Wales

[2] Guys & St Thomas Hosp, London SE1 9RT, England

[3] Inst Canc Res, Sutton, Surrey, England

来源：

CLINICAL ONCOLOGY | 2002年 / 14卷 / 04期

关键词：

D O I：

10.1053/clon.2002.0089

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：263 / 266

页数：4

共 11 条

[1]

Abe O, 1998, LANCET, V352, P930

[2] Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer [J].

Chan, S ;

Friedrichs, K ;

Noel, D ;

Pintér, T ;

Van Belle, S ;

Vorobiof, D ;

Duarte, R ;

Gil, MG ;

Bodrogi, I ;

Murray, E ;

Yelle, L ;

von Minckwitz, G ;

Korec, S ;

Simmonds, P ;

Buzzi, F ;

Mancha, RG ;

Richardson, G ;

Walpole, E ;

Ronzoni, M ;

Murawsky, M ;

Alakl, M ;

Riva, A ;

Crown, J .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2341-2354

[3] 2 MONTHS OF DOXORUBICIN-CYCLOPHOSPHAMIDE WITH AND WITHOUT INTERVAL REINDUCTION THERAPY COMPARED WITH 6 MONTHS OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN POSITIVE-NODE BREAST-CANCER PATIENTS WITH TAMOXIFEN-NONRESPONSIVE TUMORS - RESULTS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT B-15 [J].

FISHER, B ;

BROWN, AM ;

DIMITROV, NV ;

POISSON, R ;

REDMOND, C ;

MARGOLESE, RG ;

BOWMAN, D ;

WOLMARK, N ;

WICKERHAM, DL ;

KARDINAL, CG ;

SHIBATA, H ;

PATERSON, AHG ;

SUTHERLAND, CM ;

ROBERT, NJ ;

AGER, PJ ;

LEVY, L ;

WOLTER, J ;

WOZNIAK, T ;

FISHER, ER ;

DEUTSCH, M .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) :1483-1496

[4]

FUMOLEAU P, 1999, P AM SOC CLIN ONCOL, V18

[5]

Henderson IC, 1998, P AM SOC CLIN ONCOL, V17

[6]

HUTCHEON AW, 2001, BREAST CANC RES TREA, V69

[7]

LISTERSHARP D, 2000, HLTH TECHNOL ASSESS, V4

[8]

*NSABP, 2001, BREAST CANC RES TREA, V69

[9] Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: A European organization for research and treatment of cancer randomized study with cross-over [J].

Paridaens, R ;

Biganzoli, L ;

Bruning, P ;

Klijn, JGM ;

Gamucci, T ;

Houston, S ;

Coleman, R ;

Schachter, J ;

Van Vreckem, A ;

Sylvester, R ;

Awada, A ;

Wildiers, J ;

Piccart, M .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) :724-733

[10]

THOMAS E, 2000, JP AM SOC CLIN ONCOL, V19, pA74

← 1 2 →